Di Perri T, Laghi Pasini F, Pasqui A L, Ceccatelli L, Orrico A, Capecchi P L
Int J Tissue React. 1985;7(4):291-301.
Flunarizine inhibited FMLP- and A23187-induced aggregation, enzyme release and O2- generation from human PMN as a function of its concentration. A23187-dependent PMN aggregation was also studied in media devoid of Ca++ or Mg++. Flunarizine (2.4 X 10(-5)M) significantly affected not only Ca++-supported but also Mg++-sustained PMN aggregation. The inhibiting effect of the drug was reversed by increasing the level of Ca++ (1.2 mM) or Mg++ (2 mM). Nifedipine, another Ca++-entry blocker, was shown to inhibit enzyme release and O2- generation induced by FMLP and A23187 as a function of its concentration, but only slightly affected PMN aggregation at very high concentration (10(-4)M). A role for flunarizine as a specific Mg++-entry blocker is suggested.
氟桂利嗪抑制了FMLP和A23187诱导的人中性粒细胞的聚集、酶释放及超氧阴离子生成,且呈浓度依赖性。还在无钙离子或镁离子的培养基中研究了A23187依赖性中性粒细胞聚集。氟桂利嗪(2.4×10⁻⁵M)不仅显著影响钙离子支持的中性粒细胞聚集,也显著影响镁离子维持的中性粒细胞聚集。增加钙离子(1.2 mM)或镁离子(2 mM)水平可逆转该药物的抑制作用。硝苯地平,另一种钙离子内流阻滞剂,也呈浓度依赖性地抑制FMLP和A23187诱导的酶释放及超氧阴离子生成,但仅在非常高的浓度(10⁻⁴M)时对中性粒细胞聚集有轻微影响。提示氟桂利嗪具有特异性镁离子内流阻滞剂的作用。